Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
The Effect of Zingiber Officinale Extract on Preventing Demyelination of Corpus Callosum in a Rat Model of Multiple Sclerosis Publisher Pubmed



Moradi V1 ; Esfandiary E1 ; Ghanadian M2 ; Ghasemi N1 ; Rashidi B1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Anatomical Sciences, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Department of Pharmacognosy, Faculty of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran

Source: Iranian Biomedical Journal Published:2022


Abstract

Background: Multiple sclerosis is the most prevalent neurological disability of young adults. Anti-inflammatory drugs have relative effects on MS. The anti-inflammatory and antioxidative effects of Zingiber officinale (ginger) have been proven in some experimental and clinical investigations. The aim of this study was to evaluate the effects of ginger extract on preventing myelin degradation in a rat model of MS. Methods: Forty nine male Wistar rats were used in this study and divided into four control groups: the normal group, cuprizone-induced group, sham group (CPZ + NaCMC), standard control group (fingolimod + cuprizone), including three experimental groups of CPZ, each receiving three different doses of ginger extract: 150, 300, and 600mg/kg /kg/day. Results: Ginger extract of 600 mg/kg prevented CC from demyelination; however, a significant difference was observed in the fingolimod group (p < 0.05). Difference in the CPZ group was quite significant (p < 0.05). Conclusion: Treatment with ginger inhibited demyelination and alleviated remyelination of corpus callosum in rats. Therefore, it could serve as a therapeutic agent in the MS. DOI: 10.52547/ibj.2979. © 2022, Pasteur Institute of Iran. All rights reserved.
Related Docs
View other Related Docs
1. The Preventive Effect of Zingiber Officinale Essential Oil on Demyelination of Corpus Callosum in a Cuprizone Rat Model of Multiple Sclerosis, Avicenna Journal of Phytomedicine (2023)
2. The Efficacy and Safety of Ginger Supplementation in Patients With Multiple Sclerosis: A Rationale and Study Protocol for a Double-Blind Randomized Controlled Trial, Health Science Reports (2023)
3. The Effect of Ginger (Zingiber Officinale) Supplementation on Clinical, Biochemical, and Anthropometric Parameters in Patients With Multiple Sclerosis: A Double-Blind Randomized Controlled Trial, Food and Function (2023)
4. Impact of Intraventricular Human Adipose-Derived Stem Cells Transplantation With Pregnenolone Treatment on Remyelination of Corpus Callosum in a Rat Model of Multiple Sclerosis, Cell Journal (2022)
5. Improvement of Remyelination in Demyelinated Corpus Callosum Using Human Adipose-Derived Stem Cells (Hadscs) and Pregnenolone in the Cuprizone Rat Model of Multiple Sclerosis, Journal of Molecular Neuroscience (2020)
6. Astaxanthin Reduces Demyelination and Oligodendrocytes Death in a Rat Model of Multiple Sclerosis, Cell Journal (2021)
7. Evaluation of Curcumin Effects on Improvement of Muscle Strength, Prevention of Oligodendrocytes and Myelin Damage in Brain, in an Animal Model of Multiple Sclersosis (Ms), Scientific Journal of Kurdistan University of Medical Sciences (2018)
8. Evaluation of Edaravone Effects on the Differentiation of Human Adipose Derived Stem Cells Into Oligodendrocyte Cells in Multiple Sclerosis Disease in Rats, Life Sciences (2021)
Experts (# of related papers)
View all Related Experts
Masoud Etemadifar (20)
Vahid Shaygannejad (19)
Other Related Docs
9. Improvement of Myelin Ultrastructure After Transplantation of Human Adipose Tissue-Derived Stem Cell in Rat Multiple Sclerosis Model, Journal of Isfahan Medical School (2016)
10. Multiple Sclerosis: Pathogenesis, Symptoms, Diagnoses and Cell-Based Therapy, Cell Journal (2017)
11. Hydroxycitric Acid Ameliorates Inflammation and Oxidative Stress in Mouse Models of Multiple Sclerosis, Neural Regeneration Research (2016)
12. Human Placental Extract Attenuates Neurological Symptoms in the Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis-A Putative Approach in Ms Disease?, Autoimmunity Highlights (2020)
13. Evaluation of Apamin Effects on Myelination Process in C57bl/6 Mice Model of Multiple Sclerosis, Research in Pharmaceutical Sciences (2019)
14. The Role of Cobalamin in Multiple Sclerosis: An Update, Inflammation (2024)
15. The Immunomodulatory Aspect of Quercetin Penta Acetate on Th17 Cells Proliferation and Gene Expression in Multiple Sclerosis, Cell Journal (2023)
16. Remyelination Improvement After Neurotrophic Factors Secreting Cells Transplantation in Rat Spinal Cord Injury, Iranian Journal of Basic Medical Sciences (2017)
17. Rituximab and Glatiramer Acetate in Secondary Progressive Multiple Sclerosis: A Randomized Clinical Trial, Acta Neurologica Scandinavica (2021)
18. Prognostic Value of Intrathecal Igg Synthesis in Multiple Sclerosis: A Study in 54 Patients, Tehran University Medical Journal (2008)
19. Serum Uric Acid Level in Patients With Relapsing-Remitting Multiple Sclerosis, Journal of Clinical Neuroscience (2013)
20. Co-Supplementation of Synbiotics and Anti-Inflammatory-Antioxidant Rich Diet in Patients With Progressive Forms of Multiple Sclerosis: A Single-Center, Randomized Clinical Trial, Mediterranean Journal of Nutrition and Metabolism (2024)
21. Comparison of the Efficacy and Side Effects of Ifn Beta 1-A (Rebif) and a Biosimilar Product (Recigen) in Patients With Multiple Sclerosis, Journal of Isfahan Medical School (2012)
22. Th1, Th2 and Th17 Cytokine Profile in Patients With Multiple Sclerosis Following Treatment With Rapamycin, Iranian Journal of Immunology (2016)
23. Multiple Sclerosis: Pathophysiology, Clinical Features, Diagnosis, and Management, Neuroinflammation (2011)
24. Tamec: A New Analogue of Cyclomyrsinol Diterpenes Decreases Anxiety- and Depression-Like Behaviors in a Mouse Model of Multiple Sclerosis, Neurological Research (2017)
25. Valproic Acid Effects on Human Adipose-Derived Stem Cell Differentiation Into Oligodendrocytes and Improved Remyelination in a Mouse Model of Multiple Sclerosis, International Journal of Developmental Biology (2023)
26. Apamin Administration Impact on Mir-219 and Mir-155-3P Expression in Cuprizone Induced Multiple Sclerosis Model, Molecular Biology Reports (2020)
27. Vitamin D3 and Estradiol Alter Pad2 Expression and Activity Levels in C6 Glioma Cells, Multiple Sclerosis and Related Disorders (2021)
28. Direct Conversion of Somatic Cells Towards Oligodendroglial Lineage Cells: A Novel Strategy for Enhancement of Myelin Repair, Journal of Cellular Physiology (2020)
29. Elevated Serum Level of Il-4 in Neuromyelitis Optica and Multiple Sclerosis Patients, Journal of Immunoassay and Immunochemistry (2019)
30. Cytokine Gene Expression in Newly Diagnosed Multiple Sclerosis Patients, Iranian Journal of Allergy, Asthma and Immunology (2015)
31. Neutralizing Antibodies in Multiple Sclerosis Patients on Weekly Intramuscular Avonex and Biosimilar Interferon Beta-1A (Cinnovex): Comparing Results of Measurements in Two Different Laboratories, Journal of Immunological Methods (2013)
32. Comparing Side Effects of Cinnovex With Avonex in Relapsing Remitting Multiple Sclerosis Patients, Journal of Isfahan Medical School (2009)
33. Evaluation of in Vivo Lithium Chloride Effects As a Gsk3-Β Inhibitor on Human Adipose Derived Stem Cells Differentiation Into Oligodendrocytes and Re-Myelination in an Animal Model of Multiple Sclerosis, Molecular Biology Reports (2023)
34. Increased Serum Level of Il-37 in Patients With Multiple Sclerosis and Neuromyelitis Optica, Acta Neurologica Belgica (2015)
35. Evaluating the Effect of Adding Fish Oil to Fingolimod on Tnf-Α Il1β Il6, and Ifn-Γ in Patients With Relapsing-Remitting Multiple Sclerosis: A Double-Blind Randomized Placebo-Controlled Trial, Clinical Neurology and Neurosurgery (2017)
36. Serum Homocysteine Level in Patients With Multiple Sclerosis, Journal of Research in Medical Sciences (2005)
37. Nutraceuticals for Multiple Sclerosis, Bioactive Nutraceuticals for Brain Disorders (2021)
38. Immunomodulatory Effects of Cyclotides Isolated From Viola Odorata in an Experimental Autoimmune Encephalomyelitis Animal Model of Multiple Sclerosis, Multiple Sclerosis and Related Disorders (2022)
39. Serum Lipids and Cognitive Outcomes in Multiple Sclerosis; a Systematic Review and Meta-Analysis, Multiple Sclerosis and Related Disorders (2024)
40. Ermin Deficiency Leads to Compromised Myelin, Inflammatory Milieu, and Susceptibility to Demyelinating Insult, Brain Pathology (2022)
41. Multiple Sclerosis: Clinical Features, Pathophysiology, Neuroimaging and Future Therapies, Future Neurology (2009)
42. Cerebrospinal Fluid and Serum Markers of Inflammation in Patients With Multiple Sclerosis, Advances in Neuroimmune Biology (2017)
43. Interleukin-33 Plasma Levels in Patients With Relapsing-Remitting Multiple Sclerosis, Biomolecular Concepts (2017)
44. The Effect of Ifn-Β Treatment on Plasma Levels of Bdnf and Il-6 in Relapsing-Remitting Multiple Sclerosis Patients, NeuroImmunoModulation (2021)
45. A Novel Approach to Discriminate Subgroups in Multiple Sclerosis, Iranian Journal of Allergy, Asthma and Immunology (2016)
46. Evaluating the Effects of Epigallocatechin-3-Gallate on Hif-1Α Protein and Rorc Gene Expression in Peripheral Blood Mononuclear Cells in Patients With Multiple Sclerosis, Basic and Clinical Neuroscience (2021)
47. Effects of Levothyroxine on Visual Evoked Potential Impairment Following Local Injections of Lysolecithin Into the Rat Optic Chiasm, International Journal of Preventive Medicine (2018)
48. Ongoing Increase in Incidence and Prevalence of Multiple Sclerosis in South-Eastern Iran: A Three Decade Study, Multiple Sclerosis and Related Disorders (2023)
49. Bee Venom–Derived Bbb Shuttle and Its Correlation With Oligodendrocyte Proliferation Markers in Mice Model of Multiple Sclerosis, Neurotoxicity Research (2021)
50. Effect of Ginger Supplementation on Liver Enzymes: A Systematic Review and Meta-Analysis, Current Nutrition and Food Science (2024)